跳至主要内容
临床试验/NCT05267431
NCT05267431Unknown不适用

Outcomes of Different Biological Therapy on Rheumatoid Arthritis

Sohag University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Change in activity of rheumatoid arthritis

研究概览

简要总结

Evaluate effect of biological therapy on activity of RA compared to usual DMARDs

详细描述

Comparison between RA activity in both groups who recieved biological and DMARDS therapy

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • RA patients

排除标准

  • any other connective tissue disease

研究组 & 干预措施

RA patients recieved different DMARDS

RA patients recieved different DMARDS

干预措施: Biological Drug (Drug)

结局指标

主要结局

Change in activity of rheumatoid arthritis

时间窗: After 3 months of treatment

By DAS 28; it include 28 tender and swollen joints, laboratory test (ESR) and visual analogue score, if it higher than 5.1 it mean high disease activity and if lower than 3.2 it mean low activity and consider remission if lower than 2.6

次要结局

  • Activity of RA(3 months after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nesma Mansour Mohamed

Outcomes of different biological therapy on rheumatoid arthritis

Sohag University

研究点 (1)

Loading locations...

相似试验